Prostate Cancer Biomarkers– A Bench to Bedside Perspective
نویسندگان
چکیده
Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and is responsible for the second most common age-adjusted death rate due to cancer among men in the US, after lung cancer [1]. The prevalence of PCa increases with age with the chance of detecting PCa in an 80 year-old male being as high as 60% [2]. While PCa is generally considered a disease of “old age” with most men dying with and not from PCa, the mortality from PCa is still high, with estimated one PCa death globally every four minutes [3].
منابع مشابه
Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
Immunotherapy has been used for years in many types of cancer therapy. Recently, cancer immunotherapy has focused on mechanisms which can enhance the development of cell-mediated immunity. Anticancer medications are administered to inhibit immunosuppressive factors such as nagalase enzyme, which is produced by neoplastic cells and destroys macrophage activating factor (Gc-MAF). Anti-neoplastics...
متن کاملA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential
Prostate cancer (PCA) is a major health concern in current times. Ever since prostate specific antigen (PSA) was introduced in clinical practice almost three decades ago, the diagnosis and management of PCA have been revolutionized. With time, concerns arose as to the inherent shortcomings of this biomarker and alternatives were actively sought. Over the past decade new PCA biomarkers have been...
متن کاملFrom bench to bedside: the realities of reducing global prostate cancer disparity in black men
Prostate cancer in black men of African descent has a different tumour biology compared to those of other races. Its clinical manifestations depict a more aggressive disease with higher morbidity and mortality. This study proposes, through a literature search, identifying applied laboratory and clinical research in prostate cancer directed to improve outcomes and decrease global disparities of ...
متن کاملThe long journey of cancer biomarkers from the bench to the clinic.
BACKGROUND Protein cancer biomarkers serve multiple clinical purposes, both early and late, during disease progression. The search for new and better biomarkers has become an integral component of contemporary cancer research. However, the number of new biomarkers cleared by the US Food and Drug Administration has declined substantially over the last 10 years, raising concerns regarding the eff...
متن کاملBioinformatics Study of the miR-200 Family and the Target Genes in Prostate Cancer
Introduction: Considering the limitations of the common diagnostic test for prostate cancer prostate cancer, the introduction of higher-specific biomarkers for a more accurate and timely diagnosis of prostate cancer is desired. In this study, we aimed to investigate the miR-200 family (miR-200a, miR-200b, miR-200c, miR-141, and miR-429) and their target genes using bioinformatics prediction too...
متن کامل